United States · FDA National Drug Code directory
FASENRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-1745_b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe
- Product NDC
- 0310-1745
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Benralizumab
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240405
- Source listing expiry
- 20271231
Source-listed ingredients
- BENRALIZUMAB — 10 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTRIDGE in 1 CARTON (0310-1745-01) / .5 mL in 1 CARTRIDGE · 0310-1745-01
- 1 CARTRIDGE in 1 CARTON (0310-1745-95) / .5 mL in 1 CARTRIDGE · 0310-1745-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →